Moneycontrol PRO

business

Sun Pharm Q2 revenues seen up 46% to Rs 2,764 cr

Healthcare firm Sun Pharmaceutical Industries' revenues are seen going up by 46 percent YoY (of which 30.8% contribution by Taro) to Rs 2,764 crore in September quarter.

first published: Nov 8, 2012 02:05 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347